Towards the development of a fully protective Plasmodium falciparum antimalarial vaccine

If ever there were a truism then it would be that a completely protective Plasmodium falciparum malaria vaccine is desperately needed. Our institute has devoted all its efforts during the last 30 years to developing a fully protective, minimal subunit-based, multiepitope, multistage (targeting sporo...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2012

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/24048

Acceso en línea:

https://doi.org/10.1586/erv.12.57
https://repository.urosario.edu.co/handle/10336/24048

Palabra clave:

Apical merozoite antigen 1
Duffy binding like protein
Erythrocyte membrane protein 1
Major histocompatibility antigen class 2
Malaria vaccine
Merozoite surface protein
Parasite antigen
Rhoptry associated protein
Serine repeat antigen 5
Sporozoite protein
T lymphocyte receptor
Unclassified drug
Drug efficacy
Drug synthesis
Drug targeting
Human
Immunogenicity
Malaria falciparum
Merozoite
Nonhuman
Pathogenesis
Plasmodium falciparum
Plasmodium knowlesi
Plasmodium vivax
Priority journal
Protein binding
Review
Sporozoite
Drug discovery
Humans
Magnetic resonance spectroscopy
Malaria vaccines
Plasmodium falciparum
Protein conformation
Fully protective
Subunit-based
Synthetic antimalaria vaccine
subunit
falciparum
Malaria
Vaccines

Rights

License

Abierto (Texto Completo)